Randy Meier

Richard A. Meier currently works at BioMarin Pharmaceutical, Inc., as Chairman from 2023, Intersect ENT International GmbH, as Co-Managing Director, Intersect ENT GmbH, as Co-Managing Director, Syntellix AG, as Member-Supervisory Board, and Atlas Rock Co., as Partner.
Mr. Meier also formerly worked at Rockley Photonics Holdings Ltd., as President, Chief Executive Officer & Director from 2022 to 2023, STAAR Surgical Co., as Independent Director from 2011 to 2016, Greyhound Lines, Inc., as Principal, Bausch Health Americas, Inc., as Chief Financial Officer & Executive Vice President in 1999, Owens & Minor, Inc., as CFO, Executive VP & President-International from 2015 to 2018, Teleflex, Inc., as Chief Financial Officer & Executive Vice President from 2010 to 2011, Schroder & Co., Inc., as Senior Vice President from 1996 to 1998, Advanced Medical Optics, Inc., as President & Chief Operating Officer from 2007 to 2009, Intersect ENT, Inc., as Chief Financial Officer & Executive Vice President from 2019 to 2022, Australian Capital Equity Pty Ltd., as Principal, Manufacturers Hanover Corp., as Principal, and Salomon Smith Barney, Inc., as Principal.
Mr. Meier received his undergraduate degree from Princeton University.